PuSH - Publication Server of Helmholtz Zentrum München

Dawidowski, M. ; Kalel, V.C.* ; Napolitano, V.* ; Fino, R. ; Schorpp, K.K. ; Emmanouilidis, L. ; Lenhart, D. ; Ostertag, M.S. ; Kaiser, M.* ; Kolonko, M. ; Tippler, B.* ; Schliebs, W.* ; Dubin, G.* ; Mäser, P.* ; Tetko, I.V. ; Hadian, K. ; Plettenburg, O. ; Erdmann, R.* ; Sattler, M. ; Popowicz, G.M.

Structure-activity relationship in pyrazolo[4,3-c]pyridines, first inhibitors of PEX14-PEX5 Protein-Protein Interaction (PPI) with trypanocidal activity.

J. Med. Chem. 63, 847-879 (2020)
Postprint DOI PMC
Open Access Green
Trypanosoma protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against Trypanosoma is limited, and the existing therapies are partially ineffective and cause serious adverse effects. Formation of the PEX14-PEX5 complex is essential for protein import into the parasites' glycosomes. This transport is critical for parasite metabolism and failure leads to mislocalization of glycosomal enzymes, with fatal consequences for the parasite. Hence, inhibiting the PEX14-PEX5 protein protein interaction (PPI) is an attractive way to affect multiple metabolic pathways. Herein, we have used structure-guided computational screening and optimization to develop the first line of compounds that inhibit PEX14-PEX5 PPI. The optimization was driven by several X-ray structures, NMR binding data, and molecular dynamics simulations. Importantly, the developed compounds show significant cellular activity against Trypanosoma, including the human pathogen Trypanosoma brucei gambiense and Trypanosoma cruzi parasites.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.205
1.676
5
8
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Small-molecule Inhibitors; Trypanosoma-brucei; Potential Functions; Sleeping Sickness; Drug-resistance; Chagas-disease; Nitro Drugs; Import; Compartmentation; Fexinidazole
Language english
Publication Year 2020
Prepublished in Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0022-2623
e-ISSN 1520-4804
Quellenangaben Volume: 63, Issue: 2, Pages: 847-879 Article Number: , Supplement: ,
Publisher American Chemical Society (ACS)
Publishing Place 1155 16th St, Nw, Washington, Dc 20036 Usa
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503000-001
G-505293-001
G-506300-001
Scopus ID 85078521664
PubMed ID 31860309
Erfassungsdatum 2020-02-03